Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02135237 · ClinicalTrials.gov registry record · NA
Contingency Management for Alcohol Use Disorders
A NA study, sponsored by UConn Health.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT02135237 is a NA study that has completed, run by UConn Health. The registered enrollment target is 120 participants.
The verdict
NCT02135237, a NA study, has completed, sponsored by UConn Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
Contingency management (CM) treatments are highly efficacious in improving outcomes of substance abusing patients. However, CM has rarely been applied to individuals with alcohol use disorders, primarily because of technological limitations in monitoring drinking. The Secure Continuous Remote Alcohol Monitor (SCRAMx®) is a new technology designed to continuously monitor alcohol consumption 24 hours a day for 7 days per week. The purpose of this study is to evaluate the efficacy of CM in reducing alcohol use using SCRAMx. In total, 120 alcohol abusing or dependent patients initiating outpatient treatment at community-based clinics will be randomly assigned to one of two conditions: standard care, or standard care plus CM with reinforcement based on results of SCRAMx readings. Compared with standard care, it is expected that CM will result in fewer drinking days and longer durations of continuous non-drinking days.
Interventions
- BEHAVIORAL Standard Care
- BEHAVIORAL Prize Contingency Management for Alcohol Abstinence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2014-01 |
| Est. Completion | 2019-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02135237
The ClinicalTrials.gov registry entry for NCT02135237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UConn Health, which has 178 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard Care is the first listed.
NCT02135237 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02135237 about?
NCT02135237 is a clinical study titled "Contingency Management for Alcohol Use Disorders". Contingency management (CM) treatments are highly efficacious in improving outcomes of substance abusing patients. However, CM has rarely been applied to individuals with alcohol use disorders, primarily because of technological limitations in monitoring drinking. The Secure Continuous Remote Alcoho...
What is the current status of trial NCT02135237?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2014-01. Estimated completion is 2019-06.
What interventions are being tested in trial NCT02135237?
The interventions under investigation include: Standard Care (BEHAVIORAL), Prize Contingency Management for Alcohol Abstinence (BEHAVIORAL).
Who is sponsoring clinical trial NCT02135237?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.